US EditionLeidos Invests $10M in Groundbreaking AI Cancer Detection Partnership with University of Pittsburgh
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Leidos, University of Pittsburgh spend $10M for AI disease detection – RamaOnHealthcare
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases.The company is working with the University of Pittsburgh's Computational Pathology and AI Center of Excellence [...]
Leidos, University of Pittsburgh spend $10M for AI disease detection
Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases. The company is working with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE) on a five-year plan to develop AI-powered tools for faster detection of diseases, including heart disease and cancer, as well as reduced diagnostic turnaround times, allowing earlier, more productive care management. The allianc…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
